[{"Assets_0_Q2_USD":112064000.0,"CommonStockSharesOutstanding_0_Q2_shares":17834126.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19089000.0,"NetIncomeLoss_1_Q2_USD":-5903000.0,"NetIncomeLoss_2_Q2_USD":-13241000.0,"StockholdersEquity_0_Q2_USD":97787000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20191031","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191203"}]